Crocs To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Monday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.Jefferies c

BenzingaMay 13 07:31

EyePoint Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.

EyePoint Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.

Dow JonesMay 13 06:07

HC Wainwright & Co. : The EyePoint Pharmaceuticals (EYPT.US) rating was maintained, adjusted from buy to buy rating, and the target price was adjusted from $33.00 to $30.00.

HC Wainwright & Co. : The EyePoint Pharmaceuticals (EYPT.US) rating was maintained, adjusted from buy to buy rating, and the target price was adjusted from $33.00 to $30.00.

Zhitong FinanceMay 13 06:03

HC Wainwright & Co. Maintains Buy on EyePoint Pharmaceuticals, Lowers Price Target to $30

HC Wainwright & Co. analyst Yi Chen maintains EyePoint Pharmaceuticals (NASDAQ:EYPT) with a Buy and lowers the price target from $33 to $30.

BenzingaMay 13 05:57

EyePoint Pharmaceuticals: Maintaining Buy Rating Amidst Progress and Trials

TipRanksMay 13 05:25

EyePoint Pharmaceuticals Q1 2024 Earnings: Revenue Surpasses Estimates Despite Challenges

Yahoo FinanceMay 10 13:34